InvaGen to cut jobs at Central Islip and Hauppauge plants
SOURCENews reportView the filing ↗
What we know
Location: Central Islip and Hauppauge, New York, USA.
Based on news reporting.
Summary
InvaGen Pharmaceuticals Inc. plans to cut a total of 205 jobs across two Long Island factories as disclosed in WARN filings and company statements. The company will lay off 160 of 408 employees at its Central Islip factory (550 South Research Place) and 45 of 96 employees at its Hauppauge facility (600 Old Willets Path); terminations are scheduled to be completed by Dec. 20 according to the notices. InvaGen’s HR vice president confirmed the planned layoffs and said affected workers were notified in August, while parent Cipla Ltd. said the cuts are a strategic realignment toward more complex and specialized products and that the two sites will remain open. The article places the reductions in the context of Long Island’s generally expanding pharmaceutical sector and notes the layoffs won’t trigger repayment of prior tax breaks tied to the Central Islip plant.
InvaGen Pharmaceuticals, Inc. cut 205 jobs in NY as of November 27, 2026.
LayoffTalk has tracked 2 layoff events at InvaGen Pharmaceuticals, Inc. since November 2026, including 205 jobs documented in official WARN filings, with 1 additional event known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by InvaGen Pharmaceuticals, Inc..
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at InvaGen Pharmaceuticals, Inc.
Recent tracked events at this company.
Recent layoffs in NY
Other companies with tracked events in the same state.